Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay. | USF Parkinson's Disease and Movement Disorders Center

Brin, MF, CL Comella, J Jankovic, F Lai, M Naumann, and BoNTA Study Group. 2008. “Long-Term Treatment With Botulinum Toxin Type A in Cervical Dystonia Has Low Immunogenicity by Mouse Protection Assay.”. Mov Disord.

Last updated on 11/05/2024